The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Molecular Classification of Breast Carcinoma: From Traditional, Old-Fashioned Way to A New Age, and A New Way
Open accessAbstract
Breast carcinoma comprises a group of diseases with specific clinical, histopathologic and molecular properties. Traditional classification use morphology to divide tumors into separate categories with differing behavior and prognosis. However, there are limitations of traditional classification systems, and new molecular methods are expected to improve classification systems. Molecular subtypes of breast carcinomas have been characterized in the last 11 years, and have been studied extensively. Much of the information accumulated in recent years, and molecular taxonomy seems to be still developing and undergoing change. The main question is whether new molecular techniques such as gene expression profiling will be accepted as gold standard in determining breast cancer subtypes, and whether molecular classification is useful in specific subtypes of breast cancer as it is in ductal carcinoma (nonspecific type). In addition, critical review of the literature reveals major problems such as poor definition, lack of reproducibility and lack of quality control in current molecular techniques and classifications. Therefore, current molecular approaches are not yet used in routine clinical practice and treatment guidance since they are immature and can even lead to incorrect assessment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Parker, J. S., Mullins, M., Cheang, M. C. U., Leung, S., Voduc, D., Vickery, T., Davies, S., Fauron, C., He, X., Hu, Z., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1370 · Cited by 4,721
Elkablawy, M. A., Albasri, A. M., Mohammed, R. A., Hussainy, A. S., Nouh, M. M., & Alhujaily, A. S. (2016) · Saudi Medical Journal · doi:10.15537/smj.2016.2.12285 · Cited by 4,382
Metastatic Behavior of Breast Cancer Subtypes
Kennecke, H., Yerushalmi, R., Woods, R., Cheang, M. C. U., Voduc, D., Speers, C. H., Nielsen, T. O., & Gelmon, K. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.9820 · Cited by 2,262
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Cheang, M. C. U., Chia, S. K., Voduc, D., Gao, D., Leung, S., Snider, J., Watson, M., Davies, S., Bernard, P. S., Parker, J. S., et al. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp082 · Cited by 2,249
The molecular portraits of breast tumors are conserved across microarray platforms
Hu, Z., Fan, C., Oh, D. S., Marron, J., He, X., Qaqish, B. F., Livasy, C., Carey, L. A., Reynolds, E., Dressler, L., et al. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-96 · Cited by 1,491
Cheang, M. C. U., Voduc, D., Bajdik, C., Leung, S., McKinney, S., Chia, S. K., Perou, C. M., & Nielsen, T. O. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1658 · Cited by 1,195
Goldhirsch, A., Glick, J. H., Gelber, R. D., Coates, A. S., Thürlimann, B., & Senn, H.-J. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi326 · Cited by 1,127
TNM Classification of Malignant Tumours.
(1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-70-1-248_1 · Cited by 1,094
The Nottingham prognostic index in primary breast cancer
Galea, M. H., Blamey, R. W., Elston, C. E., & Ellis, I. O. (1992) · Breast Cancer Research and Treatment · doi:10.1007/bf01840834 · Cited by 1,070
Breast cancer prognostic classification in the molecular era: the role of histological grade
Rakha, E. A., Reis-Filho, J. S., Baehner, F., Dabbs, D. J., Decker, T., Eusebi, V., Fox, S. B., Ichihara, S., Jacquemier, J., Lakhani, S. R., et al. (2010) · Breast Cancer Research · doi:10.1186/bcr2607 · Cited by 1,003
Ravdin, P. M., Siminoff, L. A., Davis, G. J., Mercer, M. B., Hewlett, J., Gerson, N., & Parker, H. L. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.980 · Cited by 996
Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma
Tognon, C., Knezevich, S. R., Huntsman, D., Roskelley, C. D., Melnyk, N., Mathers, J. A., Becker, L., Carneiro, F., MacPherson, N., Horsman, D., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00180-0 · Cited by 911
Persson, M., Andrén, Y., Mark, J., Horlings, H. M., Persson, F., & Stenman, G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909114106 · Cited by 788
Weigelt, B., Horlings, H., Kreike, B., Hayes, M., Hauptmann, M., Wessels, L., de Jong, D., Van de Vijver, M., Veer, L. V., & Peterse, J. (2008) · The Journal of Pathology · doi:10.1002/path.2407 · Cited by 562
Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast.
Borst, M. J., & Ingold, J. A. (1993) · PubMed · Cited by 514
Pestalozzi, B. C., Zahrieh, D., Mallon, E., Gusterson, B. A., Price, K. N., Gelber, R. D., Holmberg, S. B., Lindtner, J., Snyder, R., Thürlimann, B., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.9336 · Cited by 491
Histological and molecular types of breast cancer: is there a unifying taxonomy?
Weigelt, B., & Reis-Filho, J. S. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.166 · Cited by 457
Breast Cancer Staging: Working With the Sixth Edition of the AJCC Cancer Staging Manual
Singletary, S. E., & Connolly, J. L. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.1.37 · Cited by 391
Breast cancer precursors revisited: molecular features and progression pathways
Lopez‐Garcia, M. A., Geyer, F. C., Lacroix‐Triki, M., Marchió, C., & Reis‐Filho, J. S. (2010) · Histopathology · doi:10.1111/j.1365-2559.2010.03568.x · Cited by 347
A Three-Gene Model to Robustly Identify Breast Cancer Molecular Subtypes
Haibe-Kains, B., Desmedt, C., Loi, S., Culhane, A. C., Bontempi, G., Quackenbush, J., & Sotiriou, C. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr545 · Cited by 313
Abdel-Fatah, T. M. A., Powe, D. G., Hodi, Z., Lee, A. H. S., Reis-Filho, J. S., & Ellis, I. O. (2007) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213368.41251.b9 · Cited by 271
Invasive lobular carcinoma of the breast: Response to hormonal therapy and outcomes
Rakha, E. A., El-Sayed, M. E., Powe, D. G., Green, A. R., Habashy, H., Grainge, M. J., Robertson, J. F. R., Blamey, R., Gee, J., Nicholson, R. I., et al. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2007.10.009 · Cited by 252
Weigelt, B., Geyer, F. C., Natrajan, R., Lopez‐Garcia, M. A., Ahmad, A. S., Savage, K., Kreike, B., & Reis‐Filho, J. S. (2010) · The Journal of Pathology · doi:10.1002/path.2629 · Cited by 234
Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast
Droufakou, S., Deshmane, V., Roylance, R., Hanby, A., Tomlinson, I., & Hart, I. R. (2001) · International Journal of Cancer · doi:10.1002/ijc.1208 · Cited by 229
Combinatorial biomarker expression in breast cancer
Rakha, E. A., Reis-Filho, J. S., & Ellis, I. O. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0746-x · Cited by 219
Molecular Classification of Breast Cancer: Limitations and Potential
Pusztai, L., Mazouni, C., Anderson, K., Wu, Y., & Symmans, W. F. (2006) · The Oncologist · doi:10.1634/theoncologist.11-8-868 · Cited by 214
Prat, A., Parker, J. S., Fan, C., & Perou, C. M. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2143-0 · Cited by 194
Sperinde, J., Jin, X., Banerjee, J., Penuel, E., Saha, A., Diedrich, G., Huang, W., Leitzel, K., Weidler, J., Ali, S. M., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0410 · Cited by 177
Staaf, J., Ringnér, M., Vallon-Christersson, J., Jönsson, G., Bendahl, P.-O., Holm, K., Arason, A., Gunnarsson, H., Hegardt, C., Agnarsson, B. A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.8775 · Cited by 175
Aberrant Expression of E-cadherin in Lobular Carcinomas of the Breast
Silva, L. D., Parry, S., Reid, L., Keith, P., Waddell, N., Kossai, M., Clarke, C., Lakhani, S. R., & Simpson, P. T. (2008) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318158d6c5 · Cited by 173
Simpson, P., Reis‐Filho, J., Lambros, M., Jones, C., Steele, D., Mackay, A., Iravani, M., Fenwick, K., Dexter, T., Jones, A., et al. (2008) · The Journal of Pathology · doi:10.1002/path.2358 · Cited by 168
Rakha, E. A., Patel, A., Powe, D. G., Benhasouna, A., Green, A. R., Lambros, M. B. K., Reis-Filho, J. S., & Ellis, I. O. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181f01916 · Cited by 161
Lobular breast carcinoma and its variants
Rakha, E. A., & Ellis, I. O. (2010) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2009.12.009 · Cited by 158
Molecular classification of breast cancer: implications for selection of adjuvant chemotherapy
Andre, F., & Pusztai, L. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0636 · Cited by 134
Mackay, A. G., Weigelt, B., Grigoriadis, A. E., Kreike, B., Natrajan, R., A’Hern, R., Tan, D. S. P., Dowsett, M., Ashworth, A., & Reis-Filho, J. S. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr071 · Cited by 131
Discovery and validation of breast cancer subtypes
Kapp, A. V., Jeffrey, S. S., Langerød, A., Børresen‐Dale, A., Han, W., Noh, D., Bukholm, I. R., Nicolau, M. M., Brown, P. O., & Tibshirani, R. J. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-231 · Cited by 129
Mechanisms of resistance to anti‐human epidermal growth factor receptor 2 agents in breast cancer
Mukohara, T. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01711.x · Cited by 123
Korde, L. A., Lusa, L., McShane, L. M., Lebowitz, P. F., Lukes, L., Camphausen, K. A., Parker, J. S., Swain, S. M., Hunter, K. W., & Zujewski, J. A. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0651-3 · Cited by 115
Geyer, F. C., & Reis-Filho, J. S. (2008) · International Journal of Surgical Pathology · doi:10.1177/1066896908328577 · Cited by 80
Gruel, N., Lucchesi, C., Raynal, V., Rodrigues, M., Pierron, G., Goudefroye, R., Cottu, P., Reyal, F., Sastre-Garau, X., Fourquet, A., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.05.013 · Cited by 70
Parra-Palau, J. L., Pedersen, K., Peg, V., Scaltriti, M., Angelini, P. D., Escorihuela, M., Mancilla, S., Sánchez‐Pla, Á., y Cajal, S. R., Baselga, J. M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1701 · Cited by 61
HER2 splice variants and their relevance in breast cancer
Sasso, M., Bianchi, F., Ciravolo, V., Tagliabue, E., & Campiglio, M. (2011) · Journal of Nucleic Acids Investigation · doi:10.4081/jnai.2011.2454 · Cited by 18
Cited by
[Retracted] Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures
Kashyap, D., Pal, D., Sharma, R., Garg, V. K., Goel, N., Koundal, D., Zaguia, A., Koundal, S., & Belay, A. (2022) · BioMed Research International · doi:10.1155/2022/9605439 · Cited by 529
RetractedArtificial intelligence-based multi-omics analysis fuels cancer precision medicine
He, X., Liu, X., Zuo, F., Shi, H., & Jing, J. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.12.009 · Cited by 445
Breast Cancer and the Other Non-Coding RNAs
Dvorská, D., Braný, D., Ňachajová, M., Halašová, E., & Danková, Z. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063280 · Cited by 38
Metadata
- Authors
- Eliyatkin, N., Yalcin, E., Zengel, B., Aktaş, S., & Vardar, E.
- Venue
- Journal of Breast Health
- Publisher
- AVES Publishing Co.
- Published
- 2015-04-07
- Volume
- 11
- Issue
- 2
- Pages
- 59-66
- ISSN
- 1306-0945 (ISSN-L)
- 2149-1976
- OpenAlex
- W2332230038
- Cited by
- 317
- References
- 49
- FWCI
- 0.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.